Characterization of a naturally occurring degradation product of the LDL receptor

Molecular Genetics and Metabolism

Volumn 105, Issue 1, 2012, Pages 149-154

  Tveten, Kristian ^a   StrØm, Thea Bismo ^a   Cameron, Jamie ^a   Holla, Øystein L ^a   Berge, Knut Erik ^a   Leren, Trond P ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cleavage; Degradation; LDL receptor; Ligand binding domain; Truncation

Indexed keywords

LOW DENSITY LIPOPROTEIN RECEPTOR; TRUNCATED LOW DENSITY LIPOPROTEIN RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BIOTINYLATION; CELL SURFACE; CONTROLLED STUDY; DEGRADATION; DNA CLEAVAGE; ENZYME RELEASE; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN SYNTHESIS; WESTERN BLOTTING;

ANIMALS; CELL MEMBRANE; CHO CELLS; CRICETINAE; CRICETULUS; CULTURE MEDIA; GOLGI APPARATUS; HUMANS; LIGANDS; MUTANT PROTEINS; PROTEASE INHIBITORS; PROTEIN STABILITY; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; PROTEOLYSIS; RECEPTORS, LDL; SEQUENCE DELETION;

EID: 84855346383     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2011.10.008     Document Type: Article

References (23)

1. Goldstein J.L., Hobbs H.H., Brown M.S. Familial hypercholesterolemia. The Metabolic & Molecular Basis of Inherited Disease 2001, 2863-2914. McGraw-Hill, New York. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.).
2. SÜdhof T.C., Goldstein J.L., Brown M.S., Russell D.W. The LDL receptor gene: a mosaic of exons shared with different proteins. Science 1985, 228:815-822.
3. Yamamoto T., Davis C.G., Brown M.S., Schneider W.J., Casey M.L., Goldstein J.L., Russell D.W. The human LDL receptor: a cysteine-rich protein with multiple Alu sequences in its mRNA. Cell 1984, 39:27-38.
4. Tolleshaug H., Goldstein J.L., Schneider W.J., Brown M.S. Posttranslational processing of the LDL receptor and its genetic disruption in familial hypercholesterolemia. Cell 1982, 30:715-724.
5. Brown M.S., Goldstein J.L. A receptor-mediated pathway for cholesterol homeostasis. Science 1986, 232:34-47.
6. Rudenko G., Henry L., Henderson K., Ichtchenko K., Brown M.S., Goldstein J.L., Deisenhofer J. Structure of the LDL receptor extracellular domain at endosomal pH. Science 2002, 298:2353-2358.
7. Brown M.S., Anderson R.G., Goldstein J.L. Recycling receptors: the round-trip itinerary of migrant membrane proteins. Cell 1983, 32:663-667.
8. Brown M.S., Herz J., Goldstein J.L. LDL-receptor structure. Calcium cages, acid baths and recycling receptors. Nature 1997, 388:629-630.
9. Mousavi S.A., Berge K.E., Leren T.P. The unique role of proprotein convertase subtilisin/kexin 9 in cholesterol homeostasis. J. Intern. Med. 2009, 266:507-519.
10. Seidah N.G., Benjannet S., Wickham L., Marcinkiewicz J., Jasmin S.B., Stifani S., Basak A., Prat A., Chretien M. Proc. Natl. Acad. Sci. USA 2003, 100:928-933.
11. Lehrman M.A., Goldstein J.L., Brown M.S., Russell D.W., Schneider W.J. Internalization-defective LDL receptors produced by genes with nonsense and frameshift mutations that truncate the cytoplasmic domain. Cell 1985, 41:735-743.
12. Webb J.C., Sun X.M., Patel D.D., McCarthy S.N., Knight B.L., Soutar A.K. Characterization of two new point mutations in the low density lipoprotein receptor genes of an English patient with homozygous familial hypercholesterolemia. J. Lipid Res. 1992, 33:689-698.
13. Strøm T.B., Holla Ø.L., Cameron J., Berge K.E., Leren T.P. Loss-of-function mutation R46L in the PCSK9 gene has little impact on the levels of total serum cholesterol in familial hypercholesterolemia heterozygotes. Clin. Chim. Acta 2010, 411:229-233.
14. Sørensen S., Ranheim T., Bakken K.S., Leren T.P., Kulseth M.A. Retention of mutant low density lipoprotein receptor in endoplasmic reticulum (ER) leads to ER stress. J. Biol. Chem. 2006, 281:468-476.
15. Tveten K., Holla Ø.L., Ranheim T., Berge K.E., Leren T.P., Kulseth M.A. 4-Phenylbutyrate restores the functionality of a misfolded mutant low-density lipoprotein receptor. FEBS J. 2007, 274:1881-1893.
16. Cameron J., Holla Ø.L., Ranheim T., Kulseth M.A., Berge K.E., Leren T.P. Effect of mutations in the PCSK9 gene on the cell surface LDL receptors. Hum. Mol. Genet. 2006, 15:1551-1558.
17. Tveten K., Ranheim T., Berge K.E., Leren T.P., Kulseth M.A. The effect of bafilomycin A1 and protease inhibitors on the degradation and recycling of a Class 5-mutant LDLR. Acta Biochim. Biophys. Sin. 2009, 4:246-255.
18. Pitas R.E., Innerarity T.L., Weinstein J.N., Mahley R.W. Acetoacetylated lipoproteins used to distinguish fibroblasts from macrophages in vitro by fluorescence microscopy. Arteriosclerosis 1981, 1:177-185.
19. Russell D.W., Brown M.S., Goldstein J.L. Different combinations of cysteine-rich repeats mediate binding of low density lipoprotein receptor to two different proteins. J. Biol. Chem. 1989, 264:21682-21688.
20. http://www.rndsystems.com/pdf/2148-LD_CF.pdf.
21. Zollner H. Handbook of Enzyme Inhibitors 1989, VCH Verlagstides gesellschaft, Weinheim.
22. Holla Ø.L., Cameron J., Tveten K., Strøm T.B., Berge K.E., Laerdahl J.K., Leren T.P. Role of the C-terminal domain of PCSK9 in degradation of the LDL receptors. J. Lipid Res. 2011, 52:1787-1794.
23. Zhang D.W., Garuti R., Tang W.J., Cohen J.C., Hobbs H.H. Structural requirements for PCSK9-mediated degradation of the low-density lipoprotein receptor. Proc. Natl. Acad. Sci. USA 2008, 105:13045-13050.